.png)
Invitation
Dear Colleagues,
On behalf of the Organizing Committee of the 34th International Congress of Antimicrobial Chemotherapy (ICC), we are delighted to extend our warmest invitation to you to be part of this prestigious event. The congress will be held at the SMX Convention Center, Manila, Philippines on December 7- 9, 2026.
We look forward to welcoming you to Manila for a premier gathering of global experts in Infectious Diseases and Microbiology, researchers, and healthcare professionals dedicated to advancing antimicrobial chemotherapy and management of infectious diseases. The Scientific Committee of the Congress has prepared an exceptional program of plenary lectures, keynote speeches, simultaneous symposia, and workshops with a line-up of world-renowned experts in the field of microbiology and antimicrobial chemotherapy. We also invite research teams to share their findings through oral and poster presentations to be chosen from submitted abstracts.
Come and be part of insightful sessions, groundbreaking research presentations, and lively discussions that will shape the future of antimicrobial use and infectious diseases.
As the biennial congress of the International Society of Antimicrobial Chemotherapy (ISAC) (http://www.isac.world) the ICC is an important event in the field of infectious diseases and clinical microbiology worldwide. In 2026, the congress will be co-hosted by the Philippine Society for Microbiology and Infectious Diseases (www.psmid.org.ph), a member of ISAC.
The 2026 Congress in Manila will provide a unique platform for professionals to interact, learn, and exchange ideas, fostering new collaborations andw partnerships. We have also planned a range of social events to enhance networking and to give you the opportunity to experience the rich cultural heritage of the Philippines.
We hope you will join us for this exciting event, which promises to be an excellent mix of academic and social programs that will educate, stimulate, and entertain. See you at the 2026 ICC Manila!
Sincerely,
The Organizing Committee of the 34th International Congress of Antimicrobial Chemotherapy (ICC)
ABOUT THE CONGRESS
The International Society of Antimicrobial Chemotherapy (ISAC) is an international society which is also a registered charity (www. ISAC.world). ISAC aims to advance the education and the science of therapy of infection through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives to those of the Charity. One of its main activities is the International Congress of Antimicrobial Chemotherapy (ICC). The ICC has been held around the globe every two years since 1959. The 34th ICC will be held at the Manila, Philippines on November, 2026., in conjunction with the Philippine Society for Microbiology and Infectious Diseases, Inc., or PSMID (https://www.psmid.org)
.png)
SCIENTIFIC PROGRAMME
| Time | Session 1 | Session 2 | Session 3 |
|---|---|---|---|
| 07:00-08:00 | Registration | ||
| 08:00-09:00 | Opening Ceremonies | ||
| 09:00-09:45 | Plenary 1: ISAC Hamao Umezawa Memorial Award Lecture | ||
| 09:45-10:30 | Plenary 2: History of Dengue Vaccination in the Philippines & The Future | ||
| 10:30-11:00 | Research Poster Session / Exhibit Visit / Coffee Break | ||
| 11:00-12:30 | Industry satellite Symposium 1 | Industry satellite Symposium 2 | Industry satellite Symposium 3 |
| 12:30-14:00 | Symposium 1: AMR AMS diagnostic stewardship Implementation of AMS in HIC Ethical dilemmas in AMS: ecology vs patient Role of diagnostic stewardship |
Symposium 2: Emerging Fungal Infections (sponsored by APSCMI) Emerging Tick Borne Infections Therapeutics for Emerging Pathogens |
Symposium 3: HIV Towards ending HIV in HIC Towards ending HIV in LMIC HIV Epidemiology and Challenges in the Philippines |
| 14:00-15:30 | Symposium 4: AMR IPC Contact precaution: is it really necessary? N95/full PPE vs surgical masks for respiratory viruses Environmental decontamination |
Symposium 5: (sponsored by ISHAM) Candida auris Fluconazole resistant Candida parapsilosis Fluconazole resistant Candida tropicalis |
Symposium 6: Viral Hepatitis HCV elimination Ending Hepatitis B: The Last Mile Challenge HDV, the neglected virus |
| 15:30-16:00 | Research Poster Session / Exhibit Visit / Coffee Break | ||
| 16:00-16:30 | Keynote 1: Asia Pacific Under the Microscope: Emerging Fungal Infections in a Changing Region | Keynote lecture 2: Pandemic preparedness research: How to prepare for the next pandemic or disease X? | Keynote lecture 3: Infection Prevention and Control, Nosocomial infections The hospital microbiome and its role in guiding environmental interventions to control nosocomial infections |
| 16:30-18:00 | Industry satellite Symposium 4 | Industry satellite Symposium 5 | Industry satellite Symposium 6 |
| 18:00-20:00 | Welcome Dinner | ||
| Time | Session 1 | Session 2 | Session 3 |
|---|---|---|---|
| 07:00-08:00 | Registration & Exhibit / Poster Viewing | ||
| 08:00-09:30 | Symposium 7: AMR diagnostics State of the art diagnostics for MDRO Cheap and effective diagnostics for MDRO MDRO Diagnostics in LMIC |
Symposium 8: Influenza Will H5N1 be the next pandemic? Towards universal influenza vaccines Treatment of influenza |
PSMID Business Meeting |
| 09:30-11:00 | Symposium 9 (or Research Forum) | Symposium 10 (ESCMID): Where are we heading with Group A Streptococcal infections? Invasive Group A Streptococcal infections - why are they more frequent? Controversies in antibiotic prophylaxis for household contacts of Invasive Group A Streptococcal patients |
PSMID Business Meeting |
| 11:00-11:30 | Research Poster Session / Exhibit Visit / Coffee Break | ||
| 11:30-13:00 | Industry satellite Symposium 7 | Industry satellite Symposium 8 | Industry satellite Symposium 9 |
| 13:00-14:30 | Industry satellite Symposium 10 | Industry satellite Symposium 11 | Industry satellite Symposium 12 |
| 14:30-15:00 | Keynote lecture 4: Multidrug Resistant Gram Negative Bacteria: What have we achieved in the past 20 years? | Keynote lecture 5: The Dr. Bienveido Alora Memorial Lecture | Keynote lecture 6: Prolonged infusions of beta-lactam antibiotics in sepsis and septic shock |
| 15:00-15:30 | Keynote lecture 7: Stopping HIV in its Tracks: Prevention, Treatment & Hope | Keynote 8: Present Status and Future of the Philippines' National Infectious Diseases Specialty Centers | Oral Research Presentation (or Another Keynote) |
| 15:30-16:00 | Research Poster Session / Exhibit Visit / Coffee Break | ||
| 16:00-16:45 | Plenary lecture 3 | ||
| 16:45-17:30 | Plenary lecture 4 | ||
| 18:00-22:00 | Optional Fellowship night with Industry lecture | ||
| Time | Session 1 | Session 2 | Session 3 |
|---|---|---|---|
| 07:00-07:30 | Registration | ||
| 07:30-08:00 | Exhibit Visit / Poster Viewing / Coffee Break | ||
| 08:00-08:45 | Plenary lecture 5 | ||
| 08:45-09:30 | Plenary lecture 6 | ||
| 09:30-10:00 | Research Poster Session / Exhibit Visit / Coffee Break | ||
| 10:00-11:30 | Symposium 11: AMR epidemiology Effective control CRE Effective control other carbapenem resistant GNB Effective control of Clostridium difficile |
Symposium 12: AMR therapeutics New antibiotics for XDR GNB Ethical dilemma in drug development: access to new antibiotics in areas of needs Repurposing old antibiotics |
Symposium 13: Dengue and other arboviruses Impact of Zika on babies and adults Climate change and dengue and other arboviruses Control of dengue via Wolbachia |
| 11:30-13:00 | Industry satellite Symposium 13 | Industry satellite Symposium 14 | Industry satellite Symposium 15 |
| 13:00-14:30 | Industry satellite Symposium 16 | Industry satellite Symposium 17 | Industry satellite Symposium 18 |
| 14:00-15:30 | Symposium 14: Vaccines Vaccine hesitancy How to improve adult vaccination How to improve pediatric vaccination after the post-pandemic vaccine hesitancy |
Symposium 15: Acinetobacter baumanii Anti-infectives Working Group Understanding the threat: epidemiology, resistance & clinical impact Decoding diverse mechanisms of resistance Lessons & successes in treating XDR Acinetobacter baumanii |
Symposium 16: co-organised by PK PD Anti-infectives Working Group PK PD to optimize treatment of MDROs PK PD in antimicrobial breakpoints PK PD in drug discovery Lessons & successes in treating XDR Acinetobacter baumanii |
| 15:30-17:00 | Symposium 17: TB Treatment of non MDR and latent TB |
Symposium 18: Malaria The Prognostication & Treatment of Malaria |
Symposium 19: Overview of ICARS Vaccines to reduce AMR in Southeast Asia |
| 16:50-18:00 | Closing Ceremonies | ||
Early Registration Deadline
28th of February 2026
Regular Registration Open
1st of March 2026
Abstract Submission and Travel Grants Application
1st of December 2025
Abstract Submission and Travel Grants Application Deadline
20th of May 2026
REGISTRATION
| Category | Early Bird Until February 28, 2026 |
Regular From March 1 Onwards |
|---|---|---|
| Philippines: PSMID Members and Trainees, DOH | ₱8,000.00 | ₱10,000.00 |
| Philippines: Fellows, Residents, Students | ₱6,000.00 | |
| Philippines: Non-PSMID Delegates | ₱9,000.00 | ₱12,000.00 |
| Overseas: ISAC Member Society | $500.00 | $600.00 |
| Overseas: Non-ISAC Member Society | $600.00 | $700.00 |
| Overseas: ISAC Member and Non-Member (LMIC/LIC) | $250.00 | $300.00 |
| Overseas Trainees | $200.00 | |
ABOUT
PROGRAMME
SPEAKERS
ABSTRACT
SPONSORSHIP
LEGAL
© Copyright 2025
ICC All Rights Reserved.